

(ShareCast News) - London-listed Shire Pharmaceuticals announced on Monday the purchase of US-based Baxalta for $32bn, eliciting a mixed reaction from...


(ShareCast News) - A handful of much-anticipated deals could be announced in the coming week, according to the Sunday newspapers, including BT's acqui...


By Carl O'Donnell Jan 7 (Reuters) - Rare disease drugmaker Shire Pharmaceuticals Plc is preparing to announce its roughly $32.5 billion acquisition of...


(ShareCast News) - The success of Shire's bid for Baxalta hinges on whether it can avoid a stiff tax bill if a large part of the transaction takes the...


(ShareCast News) - London's FTSE 100 was down 2.2% to 6,106.37 at 1418 GMT, kicking off the new year with broad-based losses following the release of ...